Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NT5E | P21589 | 5/20 | 0.38 |
| ▸ | ADORA2A | P29274 | 2/20 | 0.37 |
| ▸ | ADORA3 | P0DMS8 | 6/20 | 0.37 |
| ▸ | ADORA1 | P30542 | 5/20 | 0.37 |
| ▸ | ADORA2B | P29275 | 4/20 | 0.37 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.35 |
| ▸ | LMNA | P02545 | 1/20 | 0.35 |
| ▸ | TP53 | P04637 | 1/20 | 0.35 |
| ▸ | MAPT | P10636 | 1/20 | 0.35 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.35 |
| ▸ | HSP90B1 | P14625 | 1/20 | 0.34 |
| ▸ | ACHE | P22303 | 1/20 | 0.34 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.33 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.33 |
| ▸ | SLC29A1 | Q99808 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4948918 | 0.91 | LMNA (0.43) | NT5EADORA2AADORA3ADORA1ADORA2B | |
| SCHEMBL5498228 | 0.90 | LMNA (0.37) | NT5EADORA2AADORA3ADORA1ADORA2B | |
| SCHEMBL5735963 | 0.89 | LMNA (0.35) | NT5EADORA2AADORA3ADORA1ALDH1A1 | |
| SCHEMBL9404373 | 0.89 | LMNA (0.35) | NT5EADORA2AADORA3ADORA1ADORA2B | |
| SCHEMBL8587151 | 0.87 | ADORA3 (0.35) | NT5EADORA2AADORA3ADORA1ADORA2B | |
| SCHEMBL9791026 | 0.87 | ADORA3 (0.35) | ADORA2AADORA3ADORA1ADORA2BHSP90B1 | |
| SCHEMBL9404059 | 0.87 | LMNA (0.34) | ADORA2AADORA3ADORA1ALDH1A1LMNA | |
| SCHEMBL6386486 | 0.86 | PDE4A (0.37) | ADORA2AADORA3ADORA1ADORA2BLMNA | |
| SCHEMBL4834707 | 0.86 | PDE4A (0.37) | ADORA2AADORA3ADORA1ADORA2BLMNA | |
| SCHEMBL1120685 | 0.82 | HINT1 (0.43) | ADORA3ALDH1A1LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1446413-A4 | SYNTHESIS OF 2-ARALKOXY ADENOSINES AND 2-ALKOXYADENOSINES | KING PHARMACEUTICALS RES & DEV (US) | 2007-10-17 | — | — | EP | disclosed |
| EP-1446413-A1 | SYNTHESIS OF 2-ARALKOXY ADENOSINES AND 2-ALKOXYADENOSINES | King Pharmaceuticals Research and Development Inc. (US) | 2004-08-18 | — | — | EP | disclosed |
| WO-2003035662-A1 | SYNTHESIS OF 2-ARALKOXY ADENOSINES AND 2-ALKOXYADENOSINES | KING PHARMACEUTICALS RESEARCH & DEVELOPMENT, INC. (US) | 2003-05-01 | — | — | WO | disclosed |
| WO-2002062123-A2 | NOVEL COMPOUNDS AND METHODS FOR INHIBITING/TREATING HIV INFECTIONS AND AIDS RELATED SYMPTOMS | YALE UNIVERSITY (US) | 2002-08-15 | — | — | WO | disclosed |
| EP-0675896-A1 | PURINE DERIVATIVES | NOVO NORDISK A/S (DK) | 1995-10-11 | — | — | EP | disclosed |
| EP-0607367-A1 | NOVEL ADENOSINE DERIVATIVES | NOVO NORDISK A/S (DK) | 1994-07-27 | — | — | EP | disclosed |
| WO-1994014832-A1 | PURINE DERIVATIVES | NOVO NORDISK A/S (DK) | 1994-07-07 | — | — | WO | disclosed |
| EP-0603348-A1 | PURINE DERIVATIVES | NOVO NORDISK A/S (DK) | 1994-06-29 | — | — | EP | disclosed |
| WO-1993023418-A1 | PURINE DERIVATIVES | NOVO NORDISK A/S (DK) | 1993-11-25 | — | — | WO | disclosed |
| WO-1993023417-A1 | NOVEL ADENOSINE DERIVATIVES | NOVO NORDISK A/S (DK) | 1993-11-25 | — | — | WO | disclosed |